SCHEMBL1612154

SCHEMBL1612154

Cc1ccc2c(c1)N(c1ccccc1)c1ccc(C)cc1N2c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.42
KDM4E B2RXH2 3/20 0.42
HSD17B10 Q99714 2/20 0.42
FGFR1 P11362 1/20 0.41
LMNA P02545 3/20 0.40
TSHR P16473 2/20 0.40
MAPK1 P28482 2/20 0.40
TP53 P04637 1/20 0.40
GAA P10253 1/20 0.40
HTT P42858 1/20 0.40
HKDC1 Q2TB90 1/20 0.40
MGLL Q99685 2/20 0.38
HSP90AA1 P07900 1/20 0.38
CYP1A2 P05177 1/20 0.38
HPGD P15428 1/20 0.38
BLM P54132 1/20 0.38
OPRK1 P41145 1/20 0.38
PDE4D Q08499 1/20 0.38
CYP2A6 P11509 1/20 0.38
TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1611442 1.00 ALDH1A1 (0.42) ALDH1A1KDM4EHSD17B10FGFR1LMNA
SCHEMBL11978695 0.98 ALDH1A1 (0.41) ALDH1A1KDM4EHSD17B10FGFR1LMNA
SCHEMBL18905722 0.92 ALDH1A1 (0.41) ALDH1A1KDM4EHSD17B10FGFR1LMNA
SCHEMBL18905713 0.92 ALDH1A1 (0.41) ALDH1A1KDM4EHSD17B10FGFR1LMNA
SCHEMBL10072419 0.91 OPRK1 (0.43) ALDH1A1KDM4EHSD17B10FGFR1LMNA
SCHEMBL12841526 0.87 OPRK1 (0.40) ALDH1A1KDM4EHSD17B10FGFR1LMNA
SCHEMBL11978688 0.82 ELANE (0.50) ALDH1A1KDM4EHSD17B10LMNATSHR
SCHEMBL20789095 0.81 HSP90AA1 (0.55) ALDH1A1HSD17B10GAAMGLLHSP90AA1
SCHEMBL12374349 0.80 ALDH1A1 (0.42) ALDH1A1KDM4EHSD17B10FGFR1LMNA
SCHEMBL1610587 0.80 PDE5A (0.48) ALDH1A1KDM4EHSD17B10FGFR1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9090819-B2 Organic electroluminescent element, display device, illuminating device and condensed polycyclic heterocyclic compound Konica Minolta, Inc. (JP) 2015-07-28 US disclosed
US-9090819-B2 Organic electroluminescent element, display device, illuminating device and condensed polycyclic heterocyclic compound Konica Minolta, Inc. (JP) 2015-07-28 US disclosed
US-20120085997-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, ILLUMINATING DEVICE AND CONDENSED POLYCYCLIC HETEROCYCLIC COMPOUND KONICA MINOLTA HOLDINGS, INC. (JP) 2012-04-12 US disclosed
US-20120085997-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, ILLUMINATING DEVICE AND CONDENSED POLYCYCLIC HETEROCYCLIC COMPOUND KONICA MINOLTA HOLDINGS, INC. (JP) 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120085997-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, ILLUMINATING DEVICE AND CONDENSED POLYCYCLIC HETEROCYCLIC COMPOUND CCNE2, C1S, SCO2 ALDH1A1 177/4885KDM4E 2552/4885HSD17B10 2639/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.